| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.5 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |